Morten Schou

12.5k total citations · 1 hit paper
188 papers, 4.0k citations indexed

About

Morten Schou is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Morten Schou has authored 188 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Cardiology and Cardiovascular Medicine, 54 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Surgery. Recurrent topics in Morten Schou's work include Heart Failure Treatment and Management (75 papers), Cardiovascular Function and Risk Factors (54 papers) and Diabetes Treatment and Management (37 papers). Morten Schou is often cited by papers focused on Heart Failure Treatment and Management (75 papers), Cardiovascular Function and Risk Factors (54 papers) and Diabetes Treatment and Management (37 papers). Morten Schou collaborates with scholars based in Denmark, United States and United Kingdom. Morten Schou's co-authors include Finn Gustafsson, Caroline Kistorp, Per Hildebrandt, Lars Køber, Christian Torp‐Pedersen, Lars Videbæk, Gunnar Gislason, Jacob Eifer Møller, Jon Rasmussen and Jens Faber and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Morten Schou

168 papers receiving 3.9k citations

Hit Papers

Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
    2016 381 citations Caroline Kistorp, Pernille Holmager et al. European Journal of Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morten Schou Denmark 34 2.2k 1.3k 643 612 598 188 4.0k
Marcus Thuresson Sweden 37 1.4k 0.6× 2.3k 1.7× 995 1.5× 1.4k 2.4× 949 1.6× 123 4.9k
Chantal Kopecky Austria 18 1.3k 0.6× 612 0.5× 441 0.7× 731 1.2× 364 0.6× 40 3.1k
Robert Segal United States 24 2.8k 1.3× 845 0.6× 479 0.7× 604 1.0× 416 0.7× 65 4.1k
Jonathan M. Edelman United States 31 2.6k 1.2× 1.2k 0.9× 973 1.5× 357 0.6× 331 0.6× 90 4.6k
George Thanassoulis Canada 42 2.6k 1.2× 1.1k 0.9× 585 0.9× 2.3k 3.7× 436 0.7× 149 5.3k
Jozine M. ter Maaten Netherlands 33 2.7k 1.2× 573 0.4× 1.3k 2.1× 496 0.8× 376 0.6× 103 4.1k
Magnus Lindberg Sweden 15 1.0k 0.5× 2.4k 1.8× 607 0.9× 1.1k 1.8× 820 1.4× 63 4.1k
Alberto Palazzuoli Italy 31 2.0k 0.9× 312 0.2× 612 1.0× 771 1.3× 323 0.5× 212 3.5k
Daniel L. Dries United States 31 3.8k 1.7× 428 0.3× 787 1.2× 720 1.2× 432 0.7× 56 5.0k
Kathleen A. Jablonski United States 33 1.7k 0.8× 1.3k 1.0× 412 0.6× 2.2k 3.5× 973 1.6× 74 5.5k

Countries citing papers authored by Morten Schou

Since Specialization
Citations

This map shows the geographic impact of Morten Schou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Schou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Schou more than expected).

Fields of papers citing papers by Morten Schou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Schou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Schou. The network helps show where Morten Schou may publish in the future.

Co-authorship network of co-authors of Morten Schou

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Schou. A scholar is included among the top collaborators of Morten Schou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Schou. Morten Schou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Køber, Lars, Nadia Dridi, Morten Schou, et al.. (2024). Dapagliflozin versus empagliflozin and major adverse cardiovascular events in type 2 diabetes: a nationwide cohort study. European Heart Journal. 45(Supplement_1). 1 indexed citations
2.
Dyhl-Polk, Anne, Morten Schou, Kirsten Vistisen, et al.. (2024). 1893P Incidence of myocardial ischemia during treatment with capecitabine: Assessment with Holter recording and cardiac biomarkers. Annals of Oncology. 35. S1106–S1106.
3.
Holt, Anders, Jarl Emanuel Strange, Anne-Marie Schjerning, et al.. (2024). Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study. European Heart Journal. 45(6). 475–484. 16 indexed citations
4.
Rasmussen, Trine Bernholdt, et al.. (2024). Driving restrictions following defibrillator implantation: a nationwide register-linked survey study on the impact on employment, daily living, and driving behaviour. European Heart Journal - Quality of Care and Clinical Outcomes. 11(7). 889–899.
5.
Sun, Guoli, Emil Loldrup Fosbøl, Morten Schou, et al.. (2024). Long-term rate of ventricular arrhythmia in autoimmune disease. European Journal of Preventive Cardiology. 31(18). 2127–2134. 1 indexed citations
6.
Schou, Morten, Philip Hasbak, Andreas Kjær, et al.. (2023). The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 25(10). 2888–2896. 9 indexed citations
7.
Petersen, Jeppe Kofoed, Lauge Østergaard, Nicholas Carlson, et al.. (2023). Impact of Acute Kidney Injury After Transcatheter Aortic Valve Replacement: A Nationwide Study. Journal of the American Heart Association. 13(1). e031019–e031019. 2 indexed citations
8.
Bundgaard, Henning, Anna Axelsson Raja, Kasper Iversen, et al.. (2022). Hemodynamic Effects of Cyclic Guanosine Monophosphate-Dependent Signaling Through β3 Adrenoceptor Stimulation in Patients With Advanced Heart Failure: A Randomized Invasive Clinical Trial. Circulation Heart Failure. 15(7). e009120–e009120. 14 indexed citations
9.
Banke, Ann, Morten Schou, Marianne Ewertz, et al.. (2021). Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients. Echocardiography. 38(10). 1702–1710. 3 indexed citations
10.
Schou, Morten, Philip Hasbak, Andreas Kjær, et al.. (2021). Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial. Journal of the American Heart Association. 10(15). e020418–e020418. 22 indexed citations
11.
Modin, Daniel, Brian Claggett, Gunnar Gislason, et al.. (2019). Catheter ablation for atrial fibrillation is associated with lower incidence of heart failure and death. EP Europace. 22(1). 74–83. 9 indexed citations
12.
Holmager, Pernille, Michael Egstrup, Finn Gustafsson, et al.. (2017). Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve. BMC Cardiovascular Disorders. 17(1). 22–22. 16 indexed citations
13.
Schou, Morten, Gunnar Gislason, Lars Videbæk, et al.. (2014). Effect of Extended Follow-Up in a Specialized Heart Failure Clinic on Adherence to Guideline Recommended Therapy: NorthStar Adherence Study. European Journal of Heart Failure. 16(11). 1249–1255. 19 indexed citations
14.
15.
Schou, Morten, Christian Torp‐Pedersen, Lars Køber, et al.. (2013). Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary Care. European Journal of Heart Failure. 15(6). 671–678. 35 indexed citations
16.
Frystyk, Jan, Jens Faber, Morten Schou, et al.. (2012). α-Defensins and Outcome in Patients with Chronic Heart Failure. European Journal of Heart Failure. 14(4). 387–394. 22 indexed citations
17.
Balling, Louise, Morten Schou, Lars Videbæk, et al.. (2011). Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart Failure. European Journal of Heart Failure. 13(9). 968–973. 65 indexed citations
18.
Gustafsson, Finn, et al.. (2009). Incidence and Predictors of Hospitalization or Death in Patients Managed in Multidisciplinary Heart Failure Clinics. European Journal of Heart Failure. 11(4). 413–419. 18 indexed citations
19.
Gustafsson, Finn, Morten Schou, Lars Videbæk, et al.. (2007). Treatment with Beta-Blockers in Nurse-Led Heart Failure Clinics: Titration Efficacy and Predictors of Failure. European Journal of Heart Failure. 9(9). 910–916. 30 indexed citations
20.
Schou, Morten, Finn Gustafsson, Per Hostrup Nielsen, et al.. (2006). Unexplained Week-to-Week Variation in BNP and NT-proBNP is Low in Chronic Heart Failure Patients During Steady State. European Journal of Heart Failure. 9(1). 68–74. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus Thuresson Breakdown of academic impact, for papers by Chantal Kopecky Breakdown of academic impact, for papers by Robert Segal Breakdown of academic impact, for papers by Jonathan M. Edelman Breakdown of academic impact, for papers by George Thanassoulis Breakdown of academic impact, for papers by Jozine M. ter Maaten Breakdown of academic impact, for papers by Magnus Lindberg Breakdown of academic impact, for papers by Alberto Palazzuoli Breakdown of academic impact, for papers by Daniel L. Dries Breakdown of academic impact, for papers by Kathleen A. Jablonski
Rankless by CCL
2026